BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 19378227)

  • 1. Pulmonary hypertension in COPD: a review and consideration of the role of arterial vasodilators.
    Burger CD
    COPD; 2009 Apr; 6(2):137-44. PubMed ID: 19378227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil.
    Adnot S; Samoyeau R; Weitzenblum E
    Blood Press Suppl; 1995; 3():47-57. PubMed ID: 8535542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.
    Weitzenblum E; Chaouat A; Canuet M; Kessler R
    Semin Respir Crit Care Med; 2009 Aug; 30(4):458-70. PubMed ID: 19634085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of amlodipine on exercise-induced pulmonary hypertension and right heart function in patients with chronic obstructive pulmonary disease.
    Franz IW; Van Der Meyden J; Schaupp S; Tönnesmann U
    Z Kardiol; 2002 Oct; 91(10):833-9. PubMed ID: 12395224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cor pulmonale.
    Weitzenblum E; Chaouat A
    Chron Respir Dis; 2009; 6(3):177-85. PubMed ID: 19643833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary hypertension in COPD and interstitial lung diseases].
    Markart P; Ghofrani HA; Grimminger F; Günther A
    Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S164-6. PubMed ID: 19718606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary hypertension associated with chronic obstructive pulmonary disease.
    Chhabra SK
    Indian J Chest Dis Allied Sci; 2010; 52(1):29-40. PubMed ID: 20364612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension.
    Wang L; Jin YZ; Zhao QH; Jiang R; Wu WH; Gong SG; He J; Liu JM; Jing ZC
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3353-3360. PubMed ID: 29200842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiopulmonary exercise test characteristics in patients with chronic obstructive pulmonary disease and associated pulmonary hypertension.
    Holverda S; Bogaard HJ; Groepenhoff H; Postmus PE; Boonstra A; Vonk-Noordegraaf A
    Respiration; 2008; 76(2):160-7. PubMed ID: 17960052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heart pathology of extracardiac origin. IV. Pulmonary hypertension in chronic respiratory diseases].
    Barberà JA
    Rev Esp Cardiol; 1998 Jan; 51(1):56-68. PubMed ID: 9522610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary hypertension in chronic obstructive pulmonary disease.
    Weitzenblum E; Chaouat A; Kessler R
    Pneumonol Alergol Pol; 2013; 81(4):390-8. PubMed ID: 23744170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of pravastatin in pulmonary hypertension in chronic obstructive pulmonary disease.
    Corte TJ; Wort SJ
    Clin Sci (Lond); 2009 Mar; 116(6):493-5. PubMed ID: 19037879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease.
    Naeije R
    Proc Am Thorac Soc; 2005; 2(1):20-2. PubMed ID: 16113464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of the serotonin transporter, but not the 2a receptor or nitric oxide synthetase, are associated with pulmonary hypertension in chronic obstructive pulmonary disease.
    Ulrich S; Hersberger M; Fischler M; Nussbaumer-Ochsner Y; Treder U; Russi EW; Speich R
    Respiration; 2010; 79(4):288-95. PubMed ID: 19556740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary hypertension in COPD: pathophysiology and therapeutic targets.
    Zakynthinos E; Daniil Z; Papanikolaou J; Makris D
    Curr Drug Targets; 2011 Apr; 12(4):501-13. PubMed ID: 21194405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances in pathophysiology and management.
    Barberà JA; Blanco I
    Drugs; 2009 Jun; 69(9):1153-71. PubMed ID: 19537834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pulmonary hypertension in chronic respiratory and cardiac diseases].
    Cordier JF
    Rev Prat; 2008 Nov; 58(18):2019-23. PubMed ID: 19143273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of primary pulmonary arterial hypertension: current status].
    Solèr M
    Schweiz Med Wochenschr; 1994 Oct; 124(39):1701-7. PubMed ID: 7939536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pulmonary artery hypertension in chronic respiratory diseases].
    Oswald M; Weitzenblum E
    Rev Prat; 1991 Jun; 41(17):1548-53. PubMed ID: 1853123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary pulmonary hypertension: modes of diagnosis and aggressive treatment with vasodilators.
    Rich S
    Mt Sinai J Med; 1990 Mar; 57(2):63-74. PubMed ID: 2195321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.